Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$2.07M Sell
12,996
-885
-6% -$138K 0.41% 65
2014
Q3
$1.95M Sell
13,881
-1,527
-10% -$199K 0.37% 81
2014
Q2
$1.82M Buy
15,408
+226
+1% +$26.2K 0.35% 89
2014
Q1
$1.87M Sell
15,182
-308
-2% -$37.4K 0.35% 88
2013
Q4
$1.77M Sell
15,490
-805
-5% -$91.6K 0.32% 96
2013
Q3
$1.82M Buy
16,295
+1,707
+12% +$185K 0.32% 102
2013
Q2
$1.44M Buy
+14,588
New +$1.51M 0.3% 95

Other funds holding AMGN

Robert N. Shapiro's AMGN Position: Q4 2014 in Review

Robert N. Shapiro reduced its Amgen (AMGN) stake by 6.4% in Q4 2014, selling an estimated $138K and leaving 12,996 shares worth $2.07M. The position accounts for 0.41% of the portfolio, ranked #65.

Robert N. Shapiro first reported a position in AMGN in Q2 2013 and has held it in 7 quarters since. 1,340 funds tracked by Wall St. Rank hold AMGN as of Q4 2014.

  • Robert N. Shapiro held 12,996 shares of Amgen worth $2.07M as of Q4 2014.
  • Robert N. Shapiro sold 885 Amgen shares in Q4 2014, an estimated $138K.
  • Amgen made up 0.41% of Robert N. Shapiro's portfolio in Q4 2014, its #65 holding.
  • Robert N. Shapiro first reported a position in Amgen in Q2 2013 and has held it in 7 quarters since.
  • 1,340 funds tracked by Wall St. Rank held Amgen as of Q4 2014.

Based on Robert N. Shapiro's 13F filing for Q4 2014, filed 19 Feb 2015.